News >

Nurses Play Pivotal Role in Patient Journey Through Lung Cancer Continuum

Kristi Rosa
Published: Friday, Nov 02, 2018

Mary Pasquinelli, MS, APRN

Mary Pasquinelli, MS, APRN

With continuous advances in the lung cancer space, multidisciplinary collaboration and education are needed to ensure that the best treatment plan is selected for each particular case and that patients do well throughout treatment.

Nurses and nurse practitioners often establish relationships with patients before a diagnosis is even confirmed, and they continue to support patients throughout their journey by helping inform the development of an appropriate treatment plan and then ensuring that associated side effects are managed effectively, said Mary Pasquinelli, MS, APRN.

“Often, as a nurse practitioner, I will see that patient throughout their course of treatment and then the oncologist and I work with that patient together to see the patient when they have scans or if they have progression of disease,” Pasquinelli said. “Otherwise, I do a lot of the symptom management and diagnose, prescribe, and treat for any of the side effects.”

With the introduction of new therapies such as checkpoint inhibitors, physicians, including those outside of the oncology space, need to be made aware of how side effects associated with new approaches differ from those experienced with standard of care. Nurses often help communicate that information to ensure the best possible care for patients.

In an interview during the 2018 OncLive® State of the Science Summit™ on Non–Small Cell Lung Cancer in Chicago, Illinois, Pasquinelli, a nurse practitioner from the University of Illinois at Chicago (UIC) and director of the lung cancer screening program at UIC, discussed the pivotal role of nurses in lung cancer care.

OncLive: Nurses are sometimes the first point of contact for patients with suspected lung cancer. Can you speak to the importance of this?

Pasquinelli: Patients come in to our institutions through multiple ways, different referrals. At our hospital, we have the lung cancer screening patient and I will see all the patients that have a Lung-RADS 4 that could be suspicious of lung cancer. I also have a lung nodule clinic, and so, I may see patients in the pulmonary clinic where the patient has a high suspicion of cancer. Then we talk about these patients in the multidisciplinary tumor board and decide which way to biopsy the patient or if we should do more imaging.

Often, I have a relationship with these patients before they actually get diagnosed with cancer and then I’m there when they get diagnosed and I talk with them. One thing that I think is very important is that when we give a diagnosis, we also have a plan for them. They’re not getting called over the phone to get a diagnosis, where they don’t know what’s going to happen next. We give the diagnosis and we talk about a plan right there. We have our lung navigator with us, so he can help that patient get scheduled for the next appointments.

Often, I do have a relationship with our patients before they come. Sometimes they will call in wanting to get a second opinion, or they’re a new patient, and either I will reach out to them or to a lung navigator just to get some information. Then they kind of know who we are before they come through our door.

What are some ways that nurse practitioners serve as advocates for their patients?

We work collaboratively with the physician, but I often see the patient by myself when they’re in the clinic getting their chemotherapy—independent of the physician. But if there is a change of therapy or if there’s a question, I always have the oncologist there in the clinic so that I can discuss the case with them. I see the patients independently as long as they’re doing well.

I’m doing a lot of the symptom management, ensuring that they’re doing okay if they have any symptoms and working to resolve the symptoms. Also, I pull in resources, as needed; we distress screen every patient for anxiety and depression and we also have a screen for supportive care.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Year in Review™: Reflecting on Recent Evidence With an Eye to the Future of Lung Cancer ManagementMar 30, 20191.5
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication